| 1 |
34020723 | Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study. | 2021 May 21 |
1 |
| 2 |
34065652 | Evaluating Mechanisms of IDH1 Regulation through Site-Specific Acetylation Mimics. | 2021 May 16 |
3 |
| 3 |
32141187 | SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases. | 2020 Apr 3 |
1 |
| 4 |
29633022 | Association between mutant IDHs and tumorigenesis in gliomas. | 2018 Dec |
1 |
| 5 |
26508549 | Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1. | 2015 Dec 1 |
1 |
| 6 |
24797066 | Evolution of a transition state: role of Lys100 in the active site of isocitrate dehydrogenase. | 2014 May 26 |
2 |
| 7 |
22824796 | Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. | 2013 Jun 20 |
1 |
| 8 |
23481705 | Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas. | 2013 Apr |
1 |
| 9 |
21811504 | Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy. | 2012 |
1 |